Mother issues warning over Zofran medication during pregnancy and its dangerous consequences. From all over the nation Thousands of lawsuits have been filed against the manufacturers (GlaxoSmithKline) of Zofran. Ondansetron, popularly known as Zofran is a medication used to prevent and reduce chemotherapy and surgery related nausea and vomiting. Ondansetron may also been prescribed during pregnancy to reduce symptoms of nausea and vomiting in pregnancy (NVP,) which is sometimes referred to as “morning sickness”. Zofran administration is especially dangerous during the first trimester of pregnancy. Many doctors persisted in prescribing Ondansetron during this crucial juncture of pregnancy without caring about the repercussions of their actions.
Last year, a young mother filed a Zofran lawsuit claim with Schmidt National Law Group, and her story is one of hundreds that needs to be shared to alert women of the potential dangers of taking Zofran while pregnant. She stayed healthy and so careful during her trimesters by avoiding smoking and drinking. In addition, she and her husband have no genetic birth defects in their family history. Apparently, it came as quite a shock when their daughter was born with several major birth defects. She was prescribed Zofran her 1st, 2nd, and 3rd trimester. After delivery her daughter suffers from several conditions and birth defects include: pulmonary hypertension, PDA with bidirectional shunting, PFO (hole in heart), craniosynostosis (skull deformation), hernia, jaundice, stomach issues (multiple surgeries), sepsis, two strokes, dystopia, and a blood clot. Baby was kept under observation needs feeding tubes, tracheal tube, and a ventilator to breathe 24 hours a day, 7 days a week.
Acquiring compensation from the Zofran class-action lawsuit isn’t as important to any mother as revealing the dangerous consequence of the drug to the Public. Zofran lawsuits are being filed because the Food and Drug Administration (FDA) only approved this drug for treatment of nausea in patients recovering from surgery or chemotherapy. It was not approved as a drug for morning sickness during pregnancy. However, Doctors are still prescribing Zofran to pregnant women, likely because they believe the chances of birth defects are rare. But ask any mother whose baby was born with a birth defect and she will tell the benefits do not outweigh the risks. Until more studies are undertaken, it is unclear of the percentage of infants that may have birth defects associated with Zofran.
The manufacturers refused to warn users about the harmful side effects of Zofran. GSK presented false evidence about animal studies that showed Zofran was safe, when the results actually revealed signs of toxicity and abnormal bone growth. Zofran was not approved by the Food and Drug Administration (FDA). Despite the disapproval from the FDA the medication has gained a large market share in form of an “off label” prescription for pregnant women. Unfortunately, there’s no law stopping doctors from prescribing such drugs “off-label”.